Since 2017
Quasi Robotics was founded in 2017 by a Team of experienced engineers and entrepreneurs from the fields of Life Science, Healthcare and Artificial Intelligence. We combine the best skills in CAD/CAM design, electrical and mechanical engineering, additive manufacturing, material design, fabrication, and computer software.
Our software engineering team brings in decades of experience in core Unix technologies, databases, parallel and multi-threaded programming as well as Computer Vision, Machine Learning and Artificial Intelligence.
Quasi Robotics is supported by world-class legal, ethics, safety and compliance teams, to ensure our designs are patented, intellectual property is protected and all applicable safety and regulatory requirements are adhered to.
We are committed to driving innovation in the field of robotics and Artificial Intelligence
Our state-of-the-art systems are designed to improve efficiency, productivity, and safety in various industries, including life science and healthcare.
Our Leadership
Our leaders strive for excellence in everything that we do. We want our hardware and software to be the absolute best that they can possibly be.
Vlad Lebedev
Chief Executive OfficerMotto: 'Hire and Develop the Best'
Max Didenko
Chief Operating OfficerMotto: 'Invent and Simplify'
Fedor Bokov
Chief Scientific OfficerMotto: 'Never Stop Learning'
Strategic Advisory Board
Our strategic advisory board provides invaluable guidance and expertise to steer a company's long-term vision, enhance decision-making processes, and drive sustainable growth.
Tom Dolan
Tom is the former CEO of corporations RURO, MedLearn Media and co-founder of a global non-profit. Tom’s leadership record spans five disparate industries, two decades and he is a nationally awarded sales executive, and has sold IP and a corporation.
Mr. Curtis Gumbs
Curtis is a Scientific Manager in the department of Genomic Medicine at MD Anderson Cancer Center. Previously he performed a similar role at Duke University Medical Center in the Center for Human Genome Variation. Mr. Gumbs was an active member of the scientific team accredited with the discovery of BRCA2 and the development of a genetic test.
Cornelius Boerkoel, MD, PhD
As a physician–scientist, Neal translates basic science and technology into precision medicine and precision prevention. Currently, as president of Alamya Health, he facilitates uptake of precision genomic medicine through pioneering clinical long read sequencing and tools that enable clients to utilize genomic and epigenomic variation in health decisions.
Industries We Serve
We have carefully selected which industries we want to focus first.
Life Science
Proper Regulations, Policies, and Guidelines
Health Care
Creating Safe and Healthy Environments
Retail
Highlighting Customer Service and Security
Education
Improvement In Education